For treatment of clinical signs, including oedema and effusion, related to congestive heart failure in dogs

 Composition:

Each tablet contains  3 mg of torasemide 

 Indications:

For treatment of clinical signs, including oedema and effusion, related to congestive heart failure. 

 Administration:

 Oral use. 

UpCard tablets can be administered with or without food. 

The recommended dose of torasemide is 0.1 to 0.6 mg per kg bodyweight, once daily. The majority of dogs are stabilised at a dose of torasemide less than or equal to 0.3 mg per kg bodyweight, once daily. The dosage should be titrated to maintain patient comfort with attention to renal function and electrolytes status. If the level of diuresis requires alteration, the dose may be increased or decreased within the recommended dose range by increments of 0.1 mg/kg bodyweight. Once signs of congestive heart failure have been controlled and the patient is stable, if long term diuretic therapy with this product is required it should be continued at the lowest effective dose. 

Frequent re-examinations of the dog will enhance the establishment of an appropriate diuretic dose. 

The daily schedule of administration can be timed to control the period of micturition according to need. 

 Shelf life 

Shelf life of the veterinary medicinal product as packaged for sale: 3 years. Any remaining tablet part should be discarded after 7 days. 

 Storage 

This veterinary medicinal product does not require any special storage conditions. 
Any part tablet should be stored in the blister pack or in a closed container for a maximum of 7 days.